Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
WHO launches Target Regimen Profiles for TB treatment

Aimed at the pharmaceutical industry, research institutions, product development partnerships and donors, the new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

Published
08 September 2016
From
World Health Organization
TB Can Persist in Lungs Despite Treatment

The findings show that TB bacteria may persist in the lungs even after patients have finished treatment and are free of clinical symptoms. Although it is unclear how this might affect the risk of disease relapse, the study results underscore the need for new diagnostic methods and improved TB treatment strategies, according to the researchers.

Published
07 September 2016
From
National Institute of Allergy and Infectious Diseases
New WHO algorithm to prevent TB deaths in very ill people with HIV

The World Health Organization (WHO) has released a new diagnostic algorithm in order to reduce the likelihood of ‘seriously ill’ people with HIV dying of undiagnosed and

Published
23 August 2016
By
Theo Smart
Patients with TB and HIV should receive prompt coordinated treatment for both conditions

Tuberculosis is a leading killer of people with HIV, and providing therapy for both illnesses simultaneously saves lives - according to new guidelines on the treatment of drug-susceptible TB developed jointly by the American Thoracic Society, Centers for Disease Control and Prevention and Infectious Diseases Society of America. Treatment of TB in the presence of HIV infection is one of several special situations addressed in the new guidelines.

Published
15 August 2016
From
Eurekalert Inf Dis
A detectable CMV viral load could signal a high risk of mortality in older individuals hospitalised with HIV-associated TB

A study conducted in a cohort of hospitalised adults with HIV-associated tuberculosis (TB) co-infection from Khayelitsha found that having a detectable cytomegalovirus (CMV) viral load was associated

Published
09 August 2016
By
Theo Smart
High-dose rifampicin for TB treatment regimen may improve survival in people with low CD4 cell counts

More aggressive tuberculosis (TB) treatment using a high dose of rifampicin, in addition to antiretroviral therapy (ART), could reduce TB/HIV mortality among people with HIV/TB co-infection with

Published
26 July 2016
By
Theo Smart
Daily TB Treatment Better Than Intermittent

Patients diagnosed with tuberculosis as well as HIV do better in combating tuberculosis with an intensified daily regimen rather than intermittent therapy that delivers less medicine, researchers reported here.

Published
22 July 2016
From
MedPage Today HIV/AIDS
Shortened regimen for MDR-TB shows good results for children

The use of the shortened 9-month treatment regimen for multidrug-resistant tuberculosis (MDR-TB), known as the ‘Bangladesh regimen’ has shown to be successful in 83% of children and adolescents

Published
18 July 2016
By
Lesley Odendal
“Towards Ending the Neglect?” DNDi Releases Update on its Paediatric HIV Programme

The Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treat­ment regimen for infants and young chil­dren.

Published
17 July 2016
From
DNDi
Leave no one behind: Stop TB Partnership launches seven key population briefs

The Stop TB Partnership today launched a series of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic.

Published
17 May 2016
From
Stop TB Partnership
← First12345...15Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close